Shabir Hasham
Chief Tech/Sci/R&D Officer at SANTHERA PHARMACEUTICALS HOLDING AG
Net worth: 2 899 $ as of 31/05/2024
Network origin in Shabir Hasham first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shabir Hasham via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Medical Specialties | Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| KALA BIO, INC. | Pharmaceuticals: Major | President | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
Credit Suisse AG
 Credit Suisse AG Investment ManagersFinance Credit Suisse AG is an investment management firm headquartered in Zurich, Switzerland. The firm was founded in 1856 and was acquired by UBS Group AG (SWX: UBSG) from Credit Suisse Group AG in 2023. Credit Suisse manages global and regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals worldwide. They also offer private banking and wealth management, investment banking, and corporate and business support services. | Investment Managers | Corporate Officer/Principal | |
| University of Freiburg | College/University | Doctorate Degree | |
| The University of Manchester | College/University | Undergraduate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| State University of New York College at Cortland | College/University | Undergraduate Degree | |
| University of Aarhus | College/University | Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Director/Board Member Graduate Degree Graduate Degree | |
| University of Zurich | College/University | Graduate Degree Doctorate Degree | |
| SPEXIS AG | Pharmaceuticals: Major | Director of Finance/CFO | |
| Liverpool John Moores University | College/University | Undergraduate Degree | |
| Aventis Pharma AG | Corporate Officer/Principal | ||
| University of Sassari | College/University | Undergraduate Degree | |
| LLOYDS BANKING GROUP PLC | Major Banks | Corporate Officer/Principal | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Clearlab Europe Ltd. | Founder | ||
| Astrazeneca AG | Corporate Officer/Principal | ||
| Pfizer AG | Chief Tech/Sci/R&D Officer | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Hanken Svenska Handelshögskolan | College/University | Graduate Degree | |
Ciba, Inc
 Ciba, Inc Chemicals: SpecialtyProcess Industries Part of BASF SE, Ciba, Inc develops and produces chemicals, performance products, functional materials, and related goods. | Chemicals: Specialty | Compliance Officer | |
| University of Applied Sciences Basel | College/University | Undergraduate Degree | |
| University of Massachusetts Lowell | College/University | Undergraduate Degree | |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| Alusuisse-Lonza America, Inc. | Director of Finance/CFO | ||
| QUOTIENT LIMITED | Electronic Equipment/Instruments | Director/Board Member | |
| Caperis Partners AG | Corporate Officer/Principal | ||
Millstein & Co. LP
 Millstein & Co. LP Investment ManagersFinance Part of Guggenheim Partners LLC, Millstein & Co. LP is an alternative investment manager. The company is based in New York, NY. The CEOs are Elizabeth Abrams, James E. Millstein. The company was founded by James E. Millstein, Jim Millstein. Millstein & Co. was acquired by Guggenheim Securities LLC on September 17, 2018. | Investment Managers | Corporate Officer/Principal | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member | |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
| PERELLA WEINBERG PARTNERS | Investment Banks/Brokers | Corporate Officer/Principal | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Director/Board Member | |
Eisai Srl
 Eisai Srl Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Srl is an Italian company that manufactures and supplies pharmaceutical products. The company is based in Milan, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| Switzerland | 20 |
| United States | 14 |
| United Kingdom | 7 |
| Sweden | 5 |
| Germany | 3 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 14 |
| Finance | 8 |
| Commercial Services | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 56 |
| Corporate Officer/Principal | 41 |
| Chairman | 28 |
| Independent Dir/Board Member | 19 |
| Director of Finance/CFO | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Elmar Schnee | 31 |
| Patrick Volkert Vink | 30 |
| Martin Gertsch | 14 |
| Andrew Smith | 14 |
| Otto Schwarz | 13 |
| Christoph Rentsch | 10 |
| Thomas Meier | 9 |
| Dario Eklund | 9 |
| Stephanie Brown | 8 |
| Bradley Meyer | 8 |
| Philipp Gutzwiller | 7 |
| Kristina Sjöblom Nygren | 7 |
| Todd Bazemore | 7 |
| Sarah Holmes-Klotz | 5 |
| Neville Kodkani | 4 |
- Stock Market
- Insiders
- Shabir Hasham
- Company connections
